Monitoring and management of adverse events during mass drug administration
Date
2024-10-18Document Number
PAHO/CDE/VT/24-0006
Metadata
Show full item recordOther Language Versions
Abstract
Preventive Chemotherapy (PC) refers to the use of medications, either individually or in combination, as a key public health tool aimed at controlling and eliminating neglected infectious diseases (NIDs). These diseases disproportionately affect vulnerable populations in low-income areas. By administering medications regularly, PC helps reduce the occurrence, transmission, and severity of NIDs, as well as the long-term complications associated with them.
Enuring the safety of medications used in PC is not only a crucial technical consideration but also an ethical responsibility. It ensures that while providing health benefits to eligible populations, no harm is caused to individuals. This aligns with the fundamental principle of "do no harm" in medical practice. Furthermore, medication safety is essential for public health programs to succeed, as public trust in the safety and efficacy of these interventions is critical. From manufacturing, where medicines must meet strict quality standards, to the logistics of distribution within the supply chain, and finally, to their administration and the monitoring of any adverse effects, safety must be guaranteed at every stage.
To support national NID programs in ensuring the safe administration of medications, organizations like PAHO and WHO, in partnership with strategic stakeholders, have developed a range of practical guidelines, training materials, and tools. These resources are designed to assist in the planning, preparation, and monitoring processes that ensure medication safety. This publication outlines how to access these resources online and is further supplemented by a detailed section of frequently asked questions and their corresponding answers, specifically focused on safety considerations during the implementation of PC.
Pages
18 p.
Subject
Collections
This notice should be preserved along with the article's original URL.Attribution-NonCommercial-ShareAlike 3.0 IGO
Related items
Showing items related by title, author, creator and subject.
-
Pan American Health Organization; Communicable Diseases and Environmental Determinants of Health (CDE) (PAHOUnited StatesWashington, D.C., 2024-10-18)Neglected infectious diseases (NIDs) affect more than 1 billion people globally, causing serious long-term health effects on the most vulnerable populations. In 2020 the World Health Assembly endorsed a global road map ...
-
Pan American Health Organization; Health Systems and Services (HSS) (PAHOUnited StatesWashington, D.C., 2022)This reference document lists and provides internationally standardized case definitions of adverse events of special interest and adverse events following immunization for COVID-19 vaccines. It is based on publications, ...
-
Pan American Health Organization; Communicable Diseases and Environmental Determinants of Health (CDE) (PAHOUnited StatesWashington, D.C., 2024-10-18)The "Regional workshop on the safety of preventive chemotherapy for the elimination of neglected infectious diseases in the the Region of the Americas " was a significant event organized by the Pan American Health Organization ...